UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 198

Sortiert nach

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial

The Journal of urology, 2010-04, Vol.183 (4), p.1438-1443

2010

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Tibial Nerve Stimulation for the Long-Term Treatment of Overactive Bladder: 3-Year Results of the STEP Study

The Journal of urology, 2013-06, Vol.189 (6), p.2194-2201

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial

The Journal of urology, 2009-09, Vol.182 (3), p.1055-1061

2009

Link zum Volltext

Verfügbarkeit prüfen

Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management

International journal of clinical practice (Esher), 2020-11, Vol.74 (11), p.e13604-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome

Urology (Ridgewood, N.J.), 2019-09, Vol.131, p.77-82

2019

Link zum Volltext

Verfügbarkeit prüfen

A pilot feasibility study of treating overactive bladder patients with percutaneous saphenous nerve stimulation

Neurourology and urodynamics, 2018-06, Vol.37 (5), p.1815-1820

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Durability of Percutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder

The Journal of urology, 2010, Vol.183 (1), p.234-240

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of urology, 2009-04, Vol.181 (4), p.1764-1772

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Extended-Release Oxybutynin in Combination With Tamsulosin for Treatment of Lower Urinary Tract Symptoms in Men: Randomized, Double-Blind, Placebo-Controlled Study

Mayo Clinic proceedings, 2008-09, Vol.83 (9), p.1002-1010

2008

Link zum Volltext

Verfügbarkeit prüfen

Posterior Tibial Nerve Stimulation before a Trial of Sacral Nerve Stimulation for Refractory Urge Incontinence

The Journal of urology, 2014-06, Vol.191 (6), p.1652-1654

2014

Link zum Volltext

Verfügbarkeit prüfen

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

The American journal of medicine, 2006-03, Vol.119 (3), p.9-15

2006

Link zum Volltext

Verfügbarkeit prüfen

Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study

Neurourology and urodynamics, 2013-01, Vol.32 (1), p.24-29

2013

Link zum Volltext

Verfügbarkeit prüfen

Overactive Bladder: Practical Management

1, 2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of Pharmacodynamic Interaction of Silodosin, a Highly Selective α1a-Adrenoceptor Antagonist, With the Phosphodiesterase-5 Inhibitors Sildenafil and Tadalafil in Healthy Men

Urology (Ridgewood, N.J.), 2010-03, Vol.75 (3), p.520-525

2010

Link zum Volltext

Verfügbarkeit prüfen

Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?

BJU international, 2007-06, Vol.99 (s3), p.8-12

MacDiarmid, Scott A.

2007

Link zum Volltext

Verfügbarkeit prüfen

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

European urology, 2013-08, Vol.64 (2), p.249-256

2013

Link zum Volltext

Verfügbarkeit prüfen

MP31-01 LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY

The Journal of urology, 2017-04, Vol.197 (4), p.e398-e398

2017

Link zum Volltext

Verfügbarkeit prüfen

1343 TREATMENT INTERVAL FREQUENCY OF PERCUTANEOUS TIBIAL NERVE STIMULATION: PRELIMINARY RESULTS FROM THE STEP STUDY

The Journal of urology, 2011-04, Vol.185 (4), p.e537-e537

2011

Link zum Volltext

Verfügbarkeit prüfen

pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing

European journal of clinical pharmacology, 2010-02, Vol.66 (2), p.171-176

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder

Urology (Ridgewood, N.J.), 2011, Vol.77 (1), p.24-29

2011

Link zum Volltext

Verfügbarkeit prüfen

Combination antimuscarinics and α-blockers for benign prostatic hyperplasia

Current urology reports, 2008-07, Vol.9 (4), p.265-271

MacDiarmid, Scott A.

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician

The American journal of medicine, 2006-03, Vol.119 (3), p.24-28

2006

Link zum Volltext

Verfügbarkeit prüfen

How to choose the initial drug treatment for overactive bladder

Current urology reports, 2007-09, Vol.8 (5), p.364-369

MacDiarmid, Scott A

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

European urology, 2016-07, Vol.70 (1), p.136-145

2016

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY AND SAFETY OF EXTENDED RELEASE OXYBUTYNIN FOR THE TREATMENT OF URGE INCONTINENCE: AN ANALYSIS OF DATA FROM 3 FLEXIBLE DOSING STUDIES

The Journal of urology, 2005-10, Vol.174 (4), p.1301-1305

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(121)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial

Percutaneous Tibial Nerve Stimulation for the Long-Term Treatment of Overactive Bladder: 3-Year Results of the STEP Study

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial

Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management

A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome

A pilot feasibility study of treating overactive bladder patients with percutaneous saphenous nerve stimulation

Long-Term Durability of Percutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

Efficacy and Safety of Extended-Release Oxybutynin in Combination With Tamsulosin for Treatment of Lower Urinary Tract Symptoms in Men: Randomized, Double-Blind, Placebo-Controlled Study

Posterior Tibial Nerve Stimulation before a Trial of Sacral Nerve Stimulation for Refractory Urge Incontinence

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study

Overactive Bladder: Practical Management

Lack of Pharmacodynamic Interaction of Silodosin, a Highly Selective α1a-Adrenoceptor Antagonist, With the Phosphodiesterase-5 Inhibitors Sildenafil and Tadalafil in Healthy Men

Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

MP31-01 LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY

1343 TREATMENT INTERVAL FREQUENCY OF PERCUTANEOUS TIBIAL NERVE STIMULATION: PRELIMINARY RESULTS FROM THE STEP STUDY

pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing

Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder

Combination antimuscarinics and α-blockers for benign prostatic hyperplasia

Pharmacologic Management of Overactive Bladder: Practical Options for the Primary Care Physician

How to choose the initial drug treatment for overactive bladder

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

EFFICACY AND SAFETY OF EXTENDED RELEASE OXYBUTYNIN FOR THE TREATMENT OF URGE INCONTINENCE: AN ANALYSIS OF DATA FROM 3 FLEXIBLE DOSING STUDIES

Suchergebnisse filtern